Implant Complications and ALCL

Tuesday, May 17, 2022

1:30 PM – 2:30 PM EDT

Location: Room 102-104

Speaker(s)

Mark W. Clemens, II, MD, MBA, FACS

Associate Vice President, Professor
University of Texas MD Anderson Cancer Center
MD Anderson, University of Texas
Pearland, Texas

Slides PDF
WY

Wei-Tse Yang, MD, FSBI, FACR, MHCM

Chair
University of Texas MD Anderson Cancer Center
University of Texas MD Anderson Cancer Center
Houston, Texas

Slides PDF

This session will define implant classification by type and location and describe a range of implant complications using multimodality imaging including the advantages and disadvantages of each modality. BIA-ALCL is an uncommon T cell malignancy related to chronic exposure to textured surface breast implants. The etiology, clinical, imaging, and histopathologic manifestations as well as diagnostic and therapeutic algorithms will be presented. National and international guidelines will be presented and reviewed as applied to case examples for diagnosis and treatment of disease.

Learning Objectives:

Define implant classification by location and type and recognize the spectrum of implant complications on multimodality imaging including mammography, ultrasound, and MRI
Describe malignant implant complications including breast-implant associated anaplastic large cell lymphoma (BIA-ALCL) and list national and international guidelines for the diagnosis, work-up and management of BIA-ALCL become familiar with the etiology, clinical, and histopathologic features of BIA-ALCL
Become familiar with the etiology, clinical, and histopathologic features of BIA-ALCL and describe the imaging features of BIA-ALCL